Skip to main content
AtriCure, Inc. logo

AtriCure, Inc. — Investor Relations & Filings

Ticker · ATRC ISIN · US04963C2098 LEI · 254900B2I6GPHK2EXM59 US Manufacturing
Open in API
Filings indexed 1,189 across all filing types
Latest filing 2026-05-27 Regulatory Filings
Country US United States of America
Listing US ATRC

About AtriCure, Inc.

https://www.atricure.com

AtriCure, Inc. is a medical device company focused on developing, manufacturing, and selling technologies for the treatment of atrial fibrillation (Afib), management of the left atrial appendage (LAA), and post-operative pain. The company's product portfolio is primarily utilized by cardiothoracic surgeons and electrophysiologists. Key offerings include surgical ablation systems and the AtriClip® LAA Exclusion System, a widely implanted device for LAA management. Additionally, AtriCure provides cryoablation technology, such as the cryoXT™ Probe, which offers a non-opioid approach to pain management following surgical procedures, including amputation.

Recent filings

Filing Released Lang Actions
SD
Regulatory Filings Classification · 95% confidence The document is an SEC Form SD (Specialized Disclosure Report) filed under Rule 13p-1 for conflict minerals. It is a compliance disclosure report rather than an annual or quarterly financial report, earnings release, or management presentation. It does not present financial statements or detailed ESG performance data but serves as a regulatory filing for specialized disclosure purposes. Therefore, it falls under the general Regulatory Filings category.
2026-05-27 English
8-K
Declaration of Voting Results & Voting Rights Announcements Classification · 91% confidence The document is a Form 8-K current report that primarily discloses the official voting results from the Company’s 2026 Annual Meeting of Stockholders (Item 5.07 Submission of Matters to a Vote). It lists vote tallies for director elections, auditor ratification, plan amendments, and advisory executive compensation votes. This aligns with the “Declaration of Voting Results & Voting Rights Announcements” category.
2026-05-19 English
10-Q - AtriCure, Inc. (0001323885) (Filer)
Interim / Quarterly Report Q1 2026
2026-05-06 English
8-K - AtriCure, Inc. (0001323885) (Filer)
Report Publication Announcement Classification · 88% confidence The document is a Form 8-K current report, just under 4,000 characters, and primarily states that a press release with the first quarter financial results is furnished as Exhibit 99.1. It does not contain substantive financial data itself but is announcing and attaching a separate earnings release. Under the “menu vs meal” rule, this is an announcement of report publication, so it should be classified as Report Publication Announcement (RPA).
2026-05-05 English
DEF 14A - AtriCure, Inc. (0001323885) (Filer)
Proxy Solicitation & Information Statement
2026-04-06 English
4 - ATRICURE, INC. (0001323885) (Filer)
Director's Dealing
2026-03-03 English

Browse filings by year

17 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.